Jump to content

User:SoundsOfNature/sandbox

From Wikipedia, the free encyclopedia
C. Michael Gibson
NationalityAmerican
EducationMasters of Science and Doctor of Medicine
Alma materUniversity of Chicago and Harvard Medical School
Occupation(s)Cardiologist and Professor
Employer(s)Harvard Medical School and Beth Israel Hospital
Known forFounding WikiDoc

C. Michael Gibson is a cardiologist and professor at Harvard Medical School. He is the founder of the research organization PERFUSE and the online encyclopeadia and textbook WikiDoc. He is the namesake of a laboratory at the John Paul II Hospital and the C. Michael Gibson Research and Education Center at Istanbul University.

Education

[edit]

C. Michael Gibson attended the University of Chicago where he received a BS, MS,[1] and an MD. He was then Intern, Resident and Chief Resident at the Brigham and Women’s Hospital at the Harvard Medical School.[2]

Research

[edit]

He is the founder of the academic research organization PERFUSE (Percutaneous/Pharmacologic Endoluminal Revascularization For Unstable Syndromes Evaluation). There he has lead the angiographic analysis for more than 50 international medical and device trials. According to the American College of Cardiology Foundation and Society of Thoracic Surgeons, "Gibson’s work has largely focused on the development of statistical and angiographic methodologies to investigate the pathophysiology of coronary artery disease and the efficacy of therapeutic modalities. He has developed many of the analysis measures used as endpoints in numerous cardiovascular clinical trials, including the TIMI frame count (an index of coronary blood flow) and TIMI myocardial perfusion grade (an index of myocardial perfusion)."[3]

For example, in 2011 Gibson was a co-author on a study involving 15,500 patients that showed that Xarelto lowered the risk of heart attacks and strokes.[4][5][6] That year he was also the principal investigator of the ATLAS-ACS antithrombins trial, which was presented at the American Heart Association scientific sessions.[7] Among others, he has also led studies for implantable warning systems used to detect coronary occlusions from thrombotic events.[8] He has led or contributed to trials in the fields of acute coronary syndrome research, antiplatelet research, antithrombin research, reperfusion injury research, lipid lowering and atherosclerosis regression, new device research, CMR core laboratory research, CT angiographic core laboratory research, coronary artery bypass graft research, new electrocardiography technology, angiogenesis, stem cell therapy, National Institute of Health research, and diabetes.[1]

Publishing

[edit]

Gibson has been published in journals including Circulation,[9] The New England Journal of Medicine,[10] and Clinical Cardiology.[11] He is also a contributor and editor to the Medical Wiki Encyclopeadia[12] and founder of WikiDoc, the largest online medical encyclopeadia.[13] He is also the current chairman of the WikiDoc Foundation.[2] Gibson has been quoted regarding the clinical experiments and research of other scientists by publications including the USA Today[14] and Forbes Magazine.[15][16] He is also on the editorial boards of Circulation, Cardiac Catheterization and Intervention, and the American Heart Journal.[1]

His books include Treatment Strategies in Interventional Cardiology[17] and the Practical Handbook of Advanced Interventional Cardiology: Tips and Tricks.[18] He has contributed to books including Acute Coronary Syndromes,[19] Management of Complex Cardiovascular Problems: The Evidence-Based Medicine Approach,[20] and Primary Cardiology.[21] In all Gibson has contributed to more than 1,000 publications in his career.[1]

Tenure and professional positions

[edit]

Following the completion of his medical training Gibson served as Director of the Coronary Care Unit at Beth Israel Hospital. Gibson was then Chief of Cardiology and Director of Interventional Cardiology at the West Roxbury Veterans Affairs Medical Center and Associate Physician at the Brigham and Women’s Hospital at Harvard Medical School. He next became the Vice Chairman of Medicine for Clinical Research and Director of Invasive Cardiology at Allegheny General Hospital. Following this he served as Associate Chief of Cardiology, Chief of Interventional Cardiology, and Director of the Cardiac Catheterization Laboratory at the University of California, San Francisco Medical Center.[1][22] Gibson is now an Associate Professor of Medicine at Harvard Medical School and the Chief of Clinical Research at the Beth Israel Deaconess Medical Center Division of Cardiology.[3] In 2008 Gibson became an advisory board member for ICON Medical Imaging.[23] In 2009 he became an advisory board member for Regado Biosciences, Inc.[2]

Recognition

[edit]

The following recognitions have been received by Dr. Gibson:[1]

  • Julian and Eunice Cohen Scholar in Medicine, Harvard School of Medicine (1993)
  • Gold Medal awarded by the Institute of Geriatric Cardiology, Chinese Peoples Liberation Army General Hospital (2003)
  • The fourth recipient of the Pro Bono Curantium Gold Medal for Merit awarded by the John Paul II Hospital in Krakow, Poland, after which a laboratory at the hospital was named after him (2005)
  • The C. Michael Gibson Research and Education Center at Istanbul University is established (2009)

References

[edit]
  1. ^ a b c d e f "Professor Dr. C. Michael Gibson, M.S., M.D." New Westminster College. Retrieved June 3, 2013.
  2. ^ a b c "Executive Profile: Michael Gibson M.D." BusinessWeek. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
  3. ^ a b "C. Michael Gibson, MD, (PERFUSE)". ASCERT. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
  4. ^ Sarah Long (November 14, 2011). "Xarelto May Help Heart Patients". Third Age. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
  5. ^ Larry Husten (October 5, 2011). "ATLAS-ACS Will Be an AHA Late-Breaker". Forbes Magazine. Retrieved June 3, 2013. {{cite news}}: Italic or bold markup not allowed in: |publisher= (help)
  6. ^ David W. Freeman (November 14, 2011). "Blood thinner Xarelto cuts risk of heart attack, death in new study". CBS News. Retrieved June 3, 2013.
  7. ^ "AHA video: ATLAS-ACS: Are thrombins a better target than platelets?". Cardiovascular Business. November 13, 2011. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
  8. ^ Kaitlyn Dmyterko (September 28, 2010). "Angel Medical's coronary occlusion warning system nets CE mark". Cardiovascular Business. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
  9. ^ C. Michael Gibson; et al. "Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes". Circulation. Retrieved June 3, 2013. {{cite web}}: Explicit use of et al. in: |author= (help); Italic or bold markup not allowed in: |publisher= (help)
  10. ^ C. Michael Gibson; et al. "Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation". The New England Journal of Medicine. Retrieved June 3, 2013. {{cite web}}: Explicit use of et al. in: |author= (help); Italic or bold markup not allowed in: |publisher= (help)
  11. ^ C. Michael Gibson (February 2009). "Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)". Clinical Cardiology. Retrieved June 3, 2013. {{cite news}}: Italic or bold markup not allowed in: |publisher= (help)
  12. ^ Maria Del Sapio Garbero, Nancy Isenberg, and Maddalena Pennacchia (2010). Questioning Bodies in Shakespeare's Rome. V&R unipress. p. 306. Retrieved June 3, 2013.{{cite book}}: CS1 maint: multiple names: authors list (link)
  13. ^ Melissa Malamut (April 18, 2013). "Ask the Expert: What is Broken Heart Syndrome?". Boston Magazine. Retrieved June 3, 2013. {{cite news}}: Italic or bold markup not allowed in: |publisher= (help)
  14. ^ Carolyn Kaster (August 29, 2004). "Study: Chocolate improves vessel health". USA Today. Retrieved June 3, 2013. {{cite news}}: Italic or bold markup not allowed in: |publisher= (help)
  15. ^ Matt Herper (February 19, 2003). "Eli Lilly Changing ReoPro Pricing". Forbes Magazine. Retrieved June 3, 2013. {{cite news}}: Italic or bold markup not allowed in: |publisher= (help)
  16. ^ Robert Langreth and Matthew Herper (November 10, 2008). "J&J's High-Wire Heart Drug". Forbes Magazine. Retrieved June 3, 2013. {{cite news}}: Italic or bold markup not allowed in: |publisher= (help)
  17. ^ C. Michael Gibson (2002). Treatment Strategies in Interventional Cardiology. Pocket Medicine. Retrieved June 3, 2013.
  18. ^ C. Michael Gibson; et al. (2013). Practical Handbook of Advanced Interventional Cardiology: Tips and Tricks. John Wiley & Sons. {{cite book}}: Explicit use of et al. in: |author= (help)
  19. ^ C. Michael Gibson; et al. (2006). Acute Coronary Syndromes. Elsevier Health Sciences. Retrieved June 3, 2013. {{cite book}}: Explicit use of et al. in: |author= (help)
  20. ^ Thach Nguyen, Dayi Hu, Moo-Hyun Kim, and Cindy Grines, ed. (2008). Management of Complex Cardiovascular Problems: The Evidence-Based Medicine Approach. John Wiley & Sons.{{cite book}}: CS1 maint: multiple names: editors list (link)
  21. ^ Eugene Braunwald and Lee W. Goldman, ed. (2003). Primary Cardiology. Elsevier Health Sciences.
  22. ^ "Interest In Link Between Inflammation And Heart Disease Swells". Science Daily. November 10, 2000. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
  23. ^ "ICON Medical Imaging creates cardiac imaging advisory board". Health Imaging. July 10, 2008. Retrieved June 3, 2013. {{cite web}}: Italic or bold markup not allowed in: |publisher= (help)
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:SoundsOfNature/sandbox&oldid=1104399935"